阿莫西林联合果胶铋治疗慢性萎缩性胃炎的临床探讨

Clinical study of amoxicillin combined with bismuth pectin in the treatment of patients with chronic atrophic gastritis

目的:探讨阿莫西林联合果胶铋治疗慢性萎缩性胃炎的临床疗效。方法:收治慢性萎缩性胃炎患者100例,随机平分为两组,对照组患者采用常规克拉霉素联合果胶铋进行治疗,观察组患者采用阿莫西林联合果胶铋进行治疗。对比分析两组患者的临床疗效。结果:经过治疗后,观察组患者的总有效率96.0%,显著优于对照组的84.0%;不良反应发生率显著低于对照组,P<0.05,差异具有统计学意义。结论:对于慢性萎缩性胃炎患者,采用阿莫西林联合果胶铋进行治疗,临床效果显著,安全、可靠。

Objective:To investigate the clinical effect of amoxicillin combined with bismuth pectin in the treatment of patients with chronic atrophic gastritis.Methods:100 patients with chronic atrophic gastritis were selected,they were randomly divided into the two groups on average,patients in the control group were treated with conventional therapy of clarithromycin combined with bismuth pectin,patients in the observation group were treated with amoxicillin and bismuth pectin.We compared the clinical efficacy of the two groups after treatment.Results:After treatment,the total effective rate of the observation group 96.0% was significantly better than that of the control group with 84%,the incidence of adverse reactions was significantly lower than that of the control group,P<0.05 the differences were statistically significant.Conclusion:The clinical efficacy of amoxicillin combined with bismuth pectin in the treatment of patients with chronic atrophic gastritis is significant,safe and reliable.